Healthcare Services Company
Elan has acquired 2 companies of its own. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Elan’s largest acquisition to date was in 2000, when it acquired Dura Pharmaceuticals for $1.8B. It’s largest disclosed sale occurred in 2013, when it sold TYSABRI to Biogen for $3.3B. Elan has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include business services (50%) and healthcare services (50%).
Join Mergr and gain access to Elan’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity2
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 3
- M&A Advisors 4
Unlimited Searches
